Hong Kong Journal of Nephrology
Volume 11, Issue 1 , Pages 5-8 , April 2009

Lupus Nephritis—An Enriching Opus

  • Tak Mao Chan

      Affiliations

    • Corresponding Author InformationCorrespondence to: Professor Tak Mao Chan, Yu Professor in Nephrology and Personal Chair, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR. Fax: (+ 852) 2872-5828

REFERENCES 

  1. Li LS , Liu ZH . Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies . Kidney Int . 2004;66:920–923
  2. Chan TM , Cheng IKP , Li FK , Wong RWS , Chan KW , Wong KL . Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone . Nephron . 1995;71:321–327
  3. Chan TM , Tse KC , Tang CSO , Lai KN , Li FK . Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine . Lupus . 2005;14:265–272
  4. Illei GG , Austin HA , Crane M , Collins L , Gourley MF , Yarboro CH , et al.   Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis . Ann Intern Med . 2001;135:248–257
  5. Chan TM , Li FK , Tang CSO , Wong RW , Fang GX , Ji YL , et al.   Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group . N Engl J Med . 2000;343:1156–1162
  6. Tse KC , Tang CSO , Lio WI , Lam MF , Chan TM . Quality of life comparison between corticosteroid-and-mycofenolate mofetil and corticosteroid-and-oral cyclophosphamide in the treatment of severe lupus nephritis . Lupus . 2006;15:371–379
  7. Chan TM , Tse KC , Li FK , Tang CSO , Mok MY . Long-term study of mycophenolate mofetil as both induction and maintenance treatment for diffuse proliferative lupus nephritis . J Am Soc Nephrol . 2005;16:1076–1084
  8. Chan TM . Preventing renal failure in patients with severe lupus nephritis . Kidney Int . 2005;94:s116–s119
  9. Contreras G , Pardo V , Leclercq B , Lenz O , Tozman E , O'Nan P , et al.   Sequential therapies for proliferative lupus nephritis . N Engl J Med . 2004;350:971–980
  10. Tse KC , Tang CSO , Lam MF , Yap DYH , Chan TM . Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis . J Rheumatol . 2009;36:76–81
  11. Chan TM . Histological reclassification of lupus nephritis . Curr Opin Nephrol Hypertension . 2005;14:561–566
  12. Tse KC , Li FK , Tang SCW , Tang CSO , Lai KN , Chan TM . Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria . Lupus . 2005;14:947–952
  13. Chan TM , Li FK , Hao WK , Lui SL , Chan KW , Lai KN . Combined steroid and sequential use of cyclophosphamide followed by azathioprine in the treatment of membranous lupus nephritis with nephrotic syndrome . Lupus . 1999;8:1–7
  14. Tse KC , Lam MF , Tang S , Tang CSO , Lai KN , Chan TM . A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade . Lupus . 2007;16:46–51
  15. Chan TM . Mycophenolate mofetil in the treatment of lupus nephritis-7 years on. Eminence Based Medicine Series . Lupus . 2008;17:617–621

PII: S1561-5413(09)60002-8

doi: 10.1016/S1561-5413(09)60002-8

Hong Kong Journal of Nephrology
Volume 11, Issue 1 , Pages 5-8 , April 2009

Article Tools